• Price (EUR)17.25
  • Today's Change0.00 / 0.00%
  • Shares traded633.00
  • 1 Year change+14.36%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2021 07:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Medical Properties Trust Inc grew revenues 46.25% from 854.20m to 1.25bn while net income improved 15.15% from 374.68m to 431.45m.
Gross margin97.46%
Net profit margin36.95%
Operating margin66.86%
Return on assets3.01%
Return on equity6.77%
Return on investment3.14%
More ▼

Cash flow in USDView more

In 2020, cash reserves at Medical Properties Trust Inc fell by 911.62m. Cash Flow from Financing totalled 1.40bn or 112.15% of revenues. In addition the company generated 617.64m in cash from operations while cash used for investing totalled 2.95bn.
Cash flow per share1.46
Price/Cash flow per share14.69
Book value per share13.94
Tangible book value per share13.94
More ▼

Balance sheet in USDView more

Medical Properties Trust Inc has a Debt to Total Capital ratio of 55.01%, a lower figure than the previous year's 110.31%.
Current ratio--
Quick ratio--
Total debt/total equity1.22
Total debt/total capital0.5501
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)6.07%
Div growth rate (5 year)4.18%
Payout ratio (TTM)120.06%
EPS growth(5 years)4.98
EPS (TTM) vs
TTM 1 year ago
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.